Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023;18(1):1-42.
doi: 10.5114/pg.2023.125882. Epub 2023 Mar 15.

Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology

Affiliations

Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology

Piotr Eder et al. Prz Gastroenterol. 2023.

Erratum in

Abstract

This paper is an update of the diagnostic and therapeutic recommendations of the National Consultant for Gastroenterology and the Polish Society of Gastroenterology from 2013. It contains 49 recommendations for the diagnosis and treatment, both pharmacological and surgical, of ulcerative colitis in adults. The guidelines were developed by a group of experts appointed by the Polish Society of Gastroenterology and the National Consultant in the field of Gastroenterology. The methodology related to the GRADE methodology was used to assess the quality of available evidence and the strength of therapeutic recommendations. The degree of expert support for the proposed statements was assessed on a 6-point Likert scale. Voting results, together with comments, are included with each statement.

Keywords: colonoscopy; diagnostics; guidelines; treatment; ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

PE: Takeda, Janssen-Cilag, Pfizer, Ferring, Recordati, Bristol Myers Squibb. MŁ: Takeda, Janssen-Cilag, Astellas, Ferring. MGK: Abbvie, Astellas, Celltrion, Celgene, Janssen, Ferring, Pfizer, Pharmacosmos, Recordati, Takeda. MK: Takeda, Bristol Myers Squibb, Janssen-Cilag. JR: Takeda, Janssen-Cilag, Abbvie, Bristol-Myers Squibb. GR: Abbvie, Astellas, Janssen-Cilag, Ferring, Pfizer, Pharmacosmos, Recordati, Takeda, Bristol Myers Squibb. PR: Ferring, Janssen-Cilag, Takeda. TB: Takeda. EZ: Bristol-Myers Squibb, Ferring, Janssen-Cilag, Sandoz, Nestle, Takeda. Other co-authors do not report any conflict of interest.

Figures

Figure 1
Figure 1
Suggested algorithm for the management of dysplasia detected in colorectal cancer surveillance colonoscopy in ulcerative colitis patient HD-WLE + CE – high-definition white light endoscopy + chromoendoscopy, HGD – high-grade dysplasia, LGD – low-grade dysplasia.
Figure 2
Figure 2
Suggested cancer surveillance algorithms in a patient with primary sclerosing cholangitis PSC – primary sclerosing cholangitis, UC – ulcerative colitis, IBD – inflammatory bowel disease, US – abdominal ultrasound, MRI – magnetic resonance imaging, MRCP – magnetic resonance cholangiopancreatography, CT – computed tomography, ERCP – endoscopic retrograde cholangiopancreatography, AFP – α-fetoprotein.

References

    1. Eder P, Łodyga M, Łykowska-Szuber L, et al. Guidelines for the management of ulcerative colitis. Recommendations of the Working Group of the Polish National Consultant in Gastroenterology and the Polish Society of Gastroenterology. Gastroenterol Rev 2013; 8: 1-20. - PMC - PubMed
    1. Ramy metodyczne opracowywania postępowania diagnostyczno-terapeutycznego . Agencja Oceny Technologii Medycznych i Taryfikacji (2017). https://www.aotm.gov.pl/zalecenia-kliniczne/narzedzia/ramy-metodyczne/
    1. Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019; 68 (Suppl 3): 1-106. - PMC - PubMed
    1. Alatab S, Sepanlou SG, Ikuta K, et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2020; 5: 17-30. - PMC - PubMed
    1. Zagórowicz E, Walkiewicz D, Kucha P, et al. Nationwide data on epidemiology of inflammatory bowel disease in Poland between 2009 and 2020. Pol Arch Intern Med 2022; 132: 16194. - PubMed